Kenneth Bruce
Stock Analyst at B of A Securities
(2.07)
# 2,867
Out of 4,876 analysts
43
Total ratings
60%
Success rate
0.09%
Average return
Main Sectors:
Stocks Rated by Kenneth Bruce
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
AXP American Express Company | Upgrades: Buy | $325 → $274 | $316.08 | -13.31% | 12 | Apr 11, 2025 | |
OMF OneMain Holdings | Initiates: Buy | $49 | $56.37 | -13.07% | 4 | Jun 15, 2023 | |
HBIO Harvard Bioscience | Reiterates: Buy | $4 | $0.50 | +704.34% | 1 | Mar 10, 2023 | |
COF Capital One Financial | Downgrades: Neutral | n/a | $210.30 | - | 7 | Nov 15, 2022 | |
SYF Synchrony Financial | Upgrades: Buy | $37 | $65.84 | -43.80% | 7 | Jan 30, 2019 | |
LADR Ladder Capital | Maintains: Buy | $16 → $18 | $10.84 | +66.05% | 3 | Mar 19, 2018 | |
GPMT Granite Point Mortgage Trust | Maintains: Neutral | $20 → $18 | $2.53 | +612.87% | 1 | Nov 8, 2017 | |
CACC Credit Acceptance | Maintains: Underperform | $195 → $230 | $500.06 | -54.01% | 3 | Oct 31, 2017 | |
V Visa Inc. | Maintains: Buy | $103 → $111 | $348.47 | -68.15% | 2 | Jul 21, 2017 | |
ESNT Essent Group | Upgrades: Buy | n/a | $60.44 | - | 3 | May 9, 2017 |
American Express Company
Apr 11, 2025
Upgrades: Buy
Price Target: $325 → $274
Current: $316.08
Upside: -13.31%
OneMain Holdings
Jun 15, 2023
Initiates: Buy
Price Target: $49
Current: $56.37
Upside: -13.07%
Harvard Bioscience
Mar 10, 2023
Reiterates: Buy
Price Target: $4
Current: $0.50
Upside: +704.34%
Capital One Financial
Nov 15, 2022
Downgrades: Neutral
Price Target: n/a
Current: $210.30
Upside: -
Synchrony Financial
Jan 30, 2019
Upgrades: Buy
Price Target: $37
Current: $65.84
Upside: -43.80%
Ladder Capital
Mar 19, 2018
Maintains: Buy
Price Target: $16 → $18
Current: $10.84
Upside: +66.05%
Granite Point Mortgage Trust
Nov 8, 2017
Maintains: Neutral
Price Target: $20 → $18
Current: $2.53
Upside: +612.87%
Credit Acceptance
Oct 31, 2017
Maintains: Underperform
Price Target: $195 → $230
Current: $500.06
Upside: -54.01%
Visa Inc.
Jul 21, 2017
Maintains: Buy
Price Target: $103 → $111
Current: $348.47
Upside: -68.15%
Essent Group
May 9, 2017
Upgrades: Buy
Price Target: n/a
Current: $60.44
Upside: -